Eli Lilly will begin offering its popular new weight-loss drug Zepbound in vials—in addition to standard injection-pen devices—at about half the price of the original for certain doses.

“Today, I am pleased to see one of these manufacturers, Eli Lilly ... and syringe to pen devices. I don’t think it is a much bigger deal to use an insulin syringe vs auto injector, unless ...

Eli Lilly and Camurus have entered into partnership worth up to $870m to develop long-acting therapies in cardiometabolic ...

Eli Lilly has also raised ... who prefer vial and syringe to pen devices. I don’t think it is a much bigger deal to use an insulin syringe vs auto injector, unless someone has severe needle ...